Lexicon Pharmaceuticals (LXRX) Revenue Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn | 1,572.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,572.11% |
| Dec 31, 2025 | -79.31% |
| Sep 30, 2025 | 710.40% |
| Jun 30, 2025 | 1,652.64% |
| Mar 31, 2025 | 15.46% |
| Dec 31, 2024 | 3,366.58% |
| Sep 30, 2024 | 980.25% |
| Jun 30, 2024 | 465.98% |
| Jun 30, 2023 | 731.43% |
| Dec 31, 2020 | -97.72% |
| Jun 30, 2020 | -97.09% |
| Mar 31, 2020 | 227.96% |
| Dec 31, 2019 | -48.88% |
| Sep 30, 2019 | 4,004.36% |
| Jun 30, 2019 | -93.77% |
| Mar 31, 2019 | -90.39% |
| Dec 31, 2018 | -49.74% |
| Sep 30, 2018 | -74.83% |
| Jun 30, 2018 | 14.16% |
| Mar 31, 2018 | 41.26% |